Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Roopenian, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serreze, D. V.
Right arrow Articles by Roopenian, D. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 43, Issue 3 505-509, Copyright © 1994 by American Diabetes Association

ARTICLES

Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant

DV Serreze, EH Leiter, GJ Christianson, D Greiner and DC Roopenian
Jackson Laboratory, Bar Harbor, ME 04609.

Specific allelic combinations within the class II region of the major histocompatibility complex (MHC) represent a major genetic component for susceptibility to autoimmune insulin-dependent diabetes mellitus (IDDM) in humans. We produced and used a stock of NOD/Lt mice congenic for a functionally inactivated beta 2-microglobulin (B2mnull) locus to assess whether there was an absolute requirement for MHC class I expression and/or CD8+ T-cells in diabetogenesis. These NOD-B2mnull mice do not express cell surface MHC class I molecules or produce detectable levels of CD8+ T-cells and are diabetes and insulitis resistant. Previous results from transgenic mouse models indicated that intracellular accumulation of MHC class I molecules negatively affects pancreatic beta-cell function and can result in the development of nonautoimmune insulin-dependent diabetes mellitus (IDDM). MHC class I molecules have been shown to accumulate intracellularly in the presence of a disrupted B2m locus, but this mutation does not negatively affect plasma insulin levels in either NOD/Lt mice or in those of a mixed 129 and C57BL/6 genetic background. Interestingly, 14% of the male mice in this mixed background did develop hyperinsulinemia (> 1,500 pM) independent of the disrupted B2m locus, suggesting that these mice could conceivably develop insulin-resistant diabetes. However, none of these mice became diabetic at up to 22 months of age. Thus, elimination of cell surface MHC class I expression with a disrupted B2m gene blocks autoimmune diabetes in NOD/Lt mice, without engendering a separate, distinct form of glucose intolerance.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
H. Tsui, Y. Chan, L. Tang, S. Winer, R. K. Cheung, G. Paltser, T. Selvanantham, A. R. Elford, J. R. Ellis, D. J. Becker, et al.
Targeting of Pancreatic Glia in Type 1 Diabetes
Diabetes, April 1, 2008; 57(4): 918 - 928.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Y. Savinov, D. V. Rozanov, and A. Y. Strongin
Specific Inhibition of Autoimmune T Cell Transmigration Contributes to beta Cell Functionality and Insulin Synthesis in Non-obese Diabetic (NOD) Mice
J. Biol. Chem., November 2, 2007; 282(44): 32106 - 32111.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Jarchum, J. C. Baker, T. Yamada, T. Takaki, M. P. Marron, D. V. Serreze, and T. P. DiLorenzo
In Vivo Cytotoxicity of Insulin-Specific CD8+ T-Cells in HLA-A*0201 Transgenic NOD Mice
Diabetes, October 1, 2007; 56(10): 2551 - 2560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Blancou, R. Mallone, E. Martinuzzi, S. Severe, S. Pogu, G. Novelli, G. Bruno, B. Charbonnel, M. Dolz, L. Chaillous, et al.
Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients
J. Immunol., June 1, 2007; 178(11): 7458 - 7466.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. R. Hess, C. Barnes, M. D. Woolard, M. D. L. Johnson, J. M. Cullen, E. J. Collins, and J. A. Frelinger
Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin
Blood, April 15, 2007; 109(8): 3300 - 3307.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
W.W.J. UNGER, G.G.M. PINKSE, S. MULDER-VAN DER KRACHT, A.R. VAN DER SLIK, M.G.D. KESTER, F. OSSENDORP, J.W. DRIJFHOUT, D.V. SERREZE, and B.O. ROEP
Human Clonal CD8 Autoreactivity to an IGRP Islet Epitope Shared between Mice and Men
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 192 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
D. V. SERREZE, M. P. MARRON, and T. P. DILORENZO
"Humanized" HLA Transgenic NOD Mice to Identify Pancreatic beta Cell Autoantigens of Potential Clinical Relevance to Type 1 Diabetes
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 103 - 111.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.-M. Bach, et al.
CD8+ T-Cell Responses Identify {beta}-Cell Autoimmunity in Human Type 1 Diabetes
Diabetes, March 1, 2007; 56(3): 613 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. de Jersey, S. L. Snelgrove, S. E. Palmer, S. A. Teteris, A. Mullbacher, J. F. A. P. Miller, and R. M. Slattery
beta Cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice
PNAS, January 23, 2007; 104(4): 1295 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Casellas, A. Salavert, J. Agudo, E. Ayuso, V. Jimenez, M. Moya, S. Munoz, S. Franckhauser, and F. Bosch
Expression of IGF-I in Pancreatic Islets Prevents Lymphocytic Infiltration and Protects Mice From Type 1 Diabetes
Diabetes, December 1, 2006; 55(12): 3246 - 3255.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-G. Chen, J. Chen, M. A. Osborne, H. D. Chapman, G. S. Besra, S. A. Porcelli, E. H. Leiter, S. B. Wilson, and D. V. Serreze
CD38 Is Required for the Peripheral Survival of Immunotolerogenic CD4+ Invariant NK T Cells in Nonobese Diabetic Mice.
J. Immunol., September 1, 2006; 177(5): 2939 - 2947.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Estella, M. D. McKenzie, T. Catterall, V. R. Sutton, P. I. Bird, J. A. Trapani, T. W. Kay, and H. E. Thomas
Granzyme B-Mediated Death of Pancreatic {beta}-Cells Requires the Proapoptotic BH3-Only Molecule Bid.
Diabetes, August 1, 2006; 55(8): 2212 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. L. Hayward, N. Bautista-Lopez, K. Suzuki, A. Atrazhev, P. Dickie, and J. F. Elliott
CD4 T Cells Play Major Effector Role and CD8 T Cells Initiating Role in Spontaneous Autoimmune Myocarditis of HLA-DQ8 Transgenic IAb Knockout Nonobese Diabetic Mice.
J. Immunol., June 15, 2006; 176(12): 7715 - 7725.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C Giuliani, M Saji, I Bucci, G Fiore, M Liberatore, D S Singer, F Monaco, L D Kohn, and G Napolitano
Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells.
J. Endocrinol., June 1, 2006; 189(3): 605 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. D McKenzie, N. L Dudek, L. Mariana, M. M. Chong, J. A Trapani, T. W. Kay, and H. E Thomas
Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL
Int. Immunol., June 1, 2006; 18(6): 837 - 846.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Peng, H. Shao, Y. Ke, P. Zhang, J. Xiang, H. J. Kaplan, and D. Sun
In Vitro Activation of CD8 Interphotoreceptor Retinoid-Binding Protein-Specific T Cells Requires not only Antigenic Stimulation but also Exogenous Growth Factors.
J. Immunol., April 15, 2006; 176(8): 5006 - 5014.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Takaki, M. P. Marron, C. E. Mathews, S. T. Guttmann, R. Bottino, M. Trucco, T. P. DiLorenzo, and D. V. Serreze
HLA-A*0201-Restricted T Cells from Humanized NOD Mice Recognize Autoantigens of Potential Clinical Relevance to Type 1 Diabetes.
J. Immunol., March 1, 2006; 176(5): 3257 - 3265.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. P. Wong, L. Li, J. A. Frelinger, and R. Tisch
Early Autoimmune Destruction of Islet Grafts Is Associated with a Restricted Repertoire of IGRP-Specific CD8+ T Cells in Diabetic Nonobese Diabetic Mice
J. Immunol., February 1, 2006; 176(3): 1637 - 1644.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Cain, J. A. Smith, J. K. Ondr, B. Wang, and J. D. Katz
NKT Cells and IFN-{gamma} Establish the Regulatory Environment for the Control of Diabetogenic T Cells in the Nonobese Diabetic Mouse
J. Immunol., February 1, 2006; 176(3): 1645 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. G. M. Pinkse, O. H. M. Tysma, C. A. M. Bergen, M. G. D. Kester, F. Ossendorp, P. A. van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep
Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes
PNAS, December 20, 2005; 102(51): 18425 - 18430.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Griseri, L. Beaudoin, J. Novak, L. T. Mars, F. Lepault, R. Liblau, and A. Lehuen
Invariant NKT Cells Exacerbate Type 1 Diabetes Induced by CD8 T Cells
J. Immunol., August 15, 2005; 175(4): 2091 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Hassainya, F. Garcia-Pons, R. Kratzer, V. Lindo, F. Greer, F. A. Lemonnier, G. Niedermann, and P. M. van Endert
Identification of Naturally Processed HLA-A2--Restricted Proinsulin Epitopes by Reverse Immunology
Diabetes, July 1, 2005; 54(7): 2053 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath
Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics
J. Immunol., March 1, 2005; 174(5): 2746 - 2755.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-G. Chen, C.-M. Choisy-Rossi, T. M. Holl, H. D. Chapman, G. S. Besra, S. A. Porcelli, D. J. Shaffer, D. Roopenian, S. B. Wilson, and D. V. Serreze
Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes
J. Immunol., February 1, 2005; 174(3): 1196 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Lieberman, T. Takaki, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo
Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase
J. Immunol., December 1, 2004; 173(11): 6727 - 6734.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Qin, J. D. Trudeau, G. S. D. Reid, I-F. Lee, J. P. Dutz, P. Santamaria, C. B. Verchere, and R. Tan
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL
Int. Immunol., November 1, 2004; 16(11): 1657 - 1662.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Yang, S. Hussain, Q.-S. Mi, P. Santamaria, and T. L. Delovitch
Perturbed Homeostasis of Peripheral T Cells Elicits Decreased Susceptibility to Anti-CD3-Induced Apoptosis in Prediabetic Nonobese Diabetic Mice
J. Immunol., October 1, 2004; 173(7): 4407 - 4416.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C.-M. Choisy-Rossi, T. M. Holl, M. A. Pierce, H. D. Chapman, and D. V. Serreze
Enhanced Pathogenicity of Diabetogenic T Cells Escaping a Non-MHC Gene-Controlled Near Death Experience
J. Immunol., September 15, 2004; 173(6): 3791 - 3800.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Takaki, S. M. Lieberman, T. M. Holl, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo
Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4
J. Immunol., August 15, 2004; 173(4): 2530 - 2541.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. V. Serreze, T. M. Holl, M. P. Marron, R. T. Graser, E. A. Johnson, C. Choisy-Rossi, R. M. Slattery, S. M. Lieberman, and T. P. DiLorenzo
MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice
J. Immunol., January 15, 2004; 172(2): 871 - 879.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Yamanouchi, J. Verdaguer, B. Han, A. Amrani, P. Serra, and P. Santamaria
Cross-Priming of Diabetogenic T Cells Dissociated from CTL-Induced Shedding of {beta} Cell Autoantigens
J. Immunol., December 15, 2003; 171(12): 6900 - 6909.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
P. SANTAMARIA
Kinetic Evolution of a Diabetogenic CD8+ T Cell Response
Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 88 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. E. Hamilton-Williams, S. E. Palmer, B. Charlton, and R. M. Slattery
Beta cell MHC class I is a late requirement for diabetes
PNAS, May 27, 2003; 100(11): 6688 - 6693.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Gu, C. Wang, C. M. Roifman, and A. Cohen
Role of MHC Class I in Immune Surveillance of Mitochondrial DNA Integrity
J. Immunol., April 1, 2003; 170(7): 3603 - 3607.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Y. Savinov, F. S. Wong, A. C. Stonebraker, and A. V. Chervonsky
Presentation of Antigen by Endothelial Cells and Chemoattraction Are Required for Homing of Insulin-specific CD8+ T Cells
J. Exp. Med., March 3, 2003; 197(5): 643 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Eshima, C. Mora, F. S. Wong, E. A. Green, I. S. Grewal, and R. A. Flavell
A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse
Int. Immunol., March 1, 2003; 15(3): 351 - 357.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Sen, S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin Jr., and R. Tisch
NF-{kappa}B Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages
J. Immunol., February 15, 2003; 170(4): 1770 - 1780.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. P. Marron, R. T. Graser, H. D. Chapman, and D. V. Serreze
Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice
PNAS, October 15, 2002; 99(21): 13753 - 13758.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. S. Wong, A. K. Moustakas, L. Wen, G. K. Papadopoulos, and C. A. Janeway Jr.
Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes mellitus
PNAS, April 16, 2002; 99(8): 5551 - 5556.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. M. JEVNIKAR, S. PRANGE, P. ZUCKER, and B. SINGH
Role of Donor MHC Class III Genes in the Destruction of Transplanted Islets in NOD Mice
Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 175 - 178.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Napolitano, I. Bucci, C. Giuliani, C. Massafra, C. Di Petta, E. Devangelio, D. S. Singer, F. Monaco, and L. D. Kohn
High Glucose Levels Increase Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells and Amplify Interferon-{gamma} Action
Endocrinology, March 1, 2002; 143(3): 1008 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhang, B. O'Brien, J. Trudeau, R. Tan, P. Santamaria, and J. P. Dutz
In Situ {beta} Cell Death Promotes Priming of Diabetogenic CD8 T Lymphocytes
J. Immunol., February 1, 2002; 168(3): 1466 - 1472.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. E. Hamilton-Williams, D. V. Serreze, B. Charlton, E. A. Johnson, M. P. Marron, A. Mullbacher, and R. M. Slattery
Transgenic rescue implicates beta 2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice
PNAS, September 25, 2001; 98(20): 11533 - 11538.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Weaver Jr., B. Poligone, T. Bui, U. M. Abdel-Motal, A. S. Baldwin Jr., and R. Tisch
Dendritic Cells from Nonobese Diabetic Mice Exhibit a Defect in NF-{kappa}B Regulation Due to a Hyperactive I{kappa}B Kinase
J. Immunol., August 1, 2001; 167(3): 1461 - 1468.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. T. C. Kreuwel, J. A. Biggs, I. M. Pilip, E. G. Pamer, D. Lo, and L. A. Sherman
Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice
J. Immunol., July 15, 2001; 167(2): 1112 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. E. Pauza, A. Nguyen, T. Wolfe, I-C. Ho, L. H. Glimcher, M. von Herrath, and D. Lo
Variable Effects of Transgenic c-Maf on Autoimmune Diabetes
Diabetes, January 1, 2001; 50(1): 39 - 46.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. J. Cameron, G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch
Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes
J. Immunol., July 15, 2000; 165(2): 1102 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau
Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage
J. Immunol., July 1, 2000; 165(1): 202 - 210.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Graser, T. P. DiLorenzo, F. Wang, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze
Identification of a CD8 T Cell That Can Independently Mediate Autoimmune Diabetes Development in the Complete Absence of CD4 T Cell Helper Functions
J. Immunol., April 1, 2000; 164(7): 3913 - 3918.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
E. A. Green, F. S. Wong, K. Eshima, C. Mora, and R. A. Flavell
Neonatal Tumor Necrosis Factor {alpha} Promotes Diabetes in Nonobese Diabetic Mice by CD154-independent Antigen Presentation to CD8+ T Cells
J. Exp. Med., January 17, 2000; 191(2): 225 - 238.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. Wen, F. S. Wong, J. Tang, N.-Y. Chen, M. Altieri, C. David, R. Flavell, and R. Sherwin
In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (HLA)-DQ Molecules to the Development of Diabetes
J. Exp. Med., January 3, 2000; 191(1): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. T. C. Kreuwel, D. J. Morgan, T. Krahl, A. Ko, N. Sarvetnick, and L. A. Sherman
Comparing the Relative Role of Perforin/Granzyme Versus Fas/Fas Ligand Cytotoxic Pathways in CD8+ T Cell-Mediated Insulin-Dependent Diabetes Mellitus
J. Immunol., October 15, 1999; 163(8): 4335 - 4341.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Hattori, E. Yamato, N. Itoh, H. Senpuku, T. Fujisawa, M. Yoshino, M. Fukuda, E. Matsumoto, T. Toyonaga, I. Nakagawa, et al.
Cutting Edge: Homologous Recombination of the MHC Class I K Region Defines New MHC-Linked Diabetogenic Susceptibility Gene(s) in Nonobese Diabetic Mice
J. Immunol., August 15, 1999; 163(4): 1721 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Anderson, B.-J. Park, J. Verdaguer, A. Amrani, and P. Santamaria
Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes
PNAS, August 3, 1999; 96(16): 9311 - 9316.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Verdaguer2, A. Amrani2, B. Anderson, D. Schmidt, and P. Santamaria
Two Mechanisms for the Non-MHC-Linked Resistance to Spontaneous Autoimmunity
J. Immunol., April 15, 1999; 162(8): 4614 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
P. Hoglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis
Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes
J. Exp. Med., January 18, 1999; 189(2): 331 - 339.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. V. Serreze, S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch
B Lymphocytes Are Critical Antigen-Presenting Cells for the Initiation of T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice
J. Immunol., October 15, 1998; 161(8): 3912 - 3918.
[Abstract] [Full Text] [PDF]